IP Verse

New Alzheimer'S Disease Animal Model - EP3066203

The patent EP3066203 was granted to Centre National DE LA Recherche Scientifique Cnrs on Nov 8, 2023. The application was originally filed on Nov 5, 2014 under application number EP14793193A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3066203

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP14793193A
Filing Date
Nov 5, 2014
Status
Patent Maintained As Amended
Oct 6, 2023
Grant Date
Nov 8, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CHRISTOPH THENRUTH TIPPE SYLVIA HAMBERGERMar 22, 2021-ADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS4861719
DESCRIPTIONUS5139941
DESCRIPTIONUS5173414
DESCRIPTIONUS5278056
DESCRIPTIONUS5882877
DESCRIPTIONUS6013516
DESCRIPTIONWO9201070
DESCRIPTIONWO9303769
DESCRIPTIONWO9419478
DESCRIPTIONWO9514785
DESCRIPTIONWO9622378
INTERNATIONAL-SEARCH-REPORTWO0120977
INTERNATIONAL-SEARCH-REPORTWO02063951
INTERNATIONAL-SEARCH-REPORTWO2012049314

Non-Patent Literature (NPL) Citations (42) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- CARTIER, N. ET AL., "Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy", SCIENCE, (2009), vol. 326, pages 818 - 823-
DESCRIPTION- DEGLON, N.; HANTRAYE, P., "Viral vectors as tools to model and treat neurodegenerative disorders", THE JOURNAL OF GENE MEDICINE, (2005), vol. 7, pages 530 - 539-
DESCRIPTION- DEVI, L.; OHNO, M., "Phospho-eIF2alpha level is important for determining abilities of BACEl reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice", PLOS ONE, (2010), vol. 5, page E12974-
DESCRIPTION- DRUMMOND, E. S. ET AL., "Pathology associated with AAV mediated expression of beta amyloid or C100 in adult mouse hippocampus and cerebellum", PLOS ONE, (2013), vol. 8, page E59166-
DESCRIPTION- JAWORSKI, T. ET AL., "AAV-tau mediates pyramidal neurodegeneration by cell-cycle reentry without neurofibrillary tangle formation in wild-type mice", PLOS ONE, (2009), vol. 4, page E7280-
DESCRIPTION- KAYED, R. ET AL., "Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis", SCIENCE, (2003), vol. 300, pages 486 - 489-
DESCRIPTION- KIM, T. K. ET AL., "Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PSldE9 transgenic mouse models of Alzheimer's disease", EXPERIMENTAL & MOLECULAR MEDICINE, (2012), vol. 44, pages 492 - 502-
DESCRIPTION- KIRIK, D. ET AL., "Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system", THE JOURNAL OF NEUROSCIENCE : THE OFFICIAL JOURNAL OF THE SOCIETY FOR NEUROSCIENCE, (2002), vol. 22, pages 2780 - 2791-
DESCRIPTION- LAWLOR, P. A. ET AL., "Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels", MOLECULAR NEURODEGENERATION, (2007), vol. 2, page 11-
DESCRIPTION- LEE, J. E.; HAN, P. L., "An update of animal models of Alzheimer's disease with a reevaluation of plaque depositions", EXPERIMENTAL NEUROBIOLOGY, (2013), vol. 22, pages 84 - 95-
DESCRIPTION- LEE, K. W. ET AL., "Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein", NEUROBIOLOGY OF DISEASE, (2006), vol. 22, pages 10 - 24-
DESCRIPTION- LEWIS, J. ET AL., "Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP", SCIENCE, (2001), vol. 293, pages 1487 - 1491-
DESCRIPTION- LO BIANCO, C.; RIDET, J. L.; SCHNEIDER, B. L.; DEGLON, N.; AEBISCHER, P., "alpha - Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2002), vol. 99, pages 10813 - 10818-
DESCRIPTION- MCGOWAN, E. ET AL., "Abeta42 is essential for parenchymal and vascular amyloid deposition in mice", NEURON, (2005), vol. 47, pages 191 - 199-
DESCRIPTION- NALBANTOGLU, J. ET AL., "Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein", NATURE, (1997), vol. 387, pages 500 - 505-
DESCRIPTION- ODDO, S.; CACCAMO, A.; KITAZAWA, M.; TSENG, B. P.; LAFERLA, F. M., "Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease", NEUROBIOLOGY OF AGING, (2003), vol. 24, pages 1063 - 1070-
DESCRIPTION- PALOP, J. J. ET AL., "Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2003), vol. 100, pages 9572 - 9577-
DESCRIPTION- SCHINDOWSKI, K. ET AL., "Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits", THE AMERICAN JOURNAL OF PATHOLOGY, (2006), vol. 169, pages 599 - 616-
DESCRIPTION- SELKOE, D. J., "Presenilin, Notch, and the genesis and treatment of Alzheimer's disease", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2001), vol. 98, pages 11039 - 11041-
DESCRIPTION- TANEMURA, K. ET AL., "Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau", THE JOURNAL OF NEUROSCIENCE : THE OFFICIAL JOURNAL OF THE SOCIETY FOR NEUROSCIENCE, (2002), vol. 22, pages 133 - 141-
DESCRIPTION- WEISS, C. ET AL., "Impaired eyeblink conditioning and decreased hippocampal volume in PDAPP V717F mice", NEUROBIOLOGY OF DISEASE, (2002), vol. 11, pages 425 - 433-
DESCRIPTION- WESTERMAN, M. A. ET AL., "The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease", THE JOURNAL OF NEUROSCIENCE : THE OFFICIAL JOURNAL OF THE SOCIETY FOR NEUROSCIENCE, (2002), vol. 22, pages 1858 - 1867-
DESCRIPTION- WOLF, S. A. ET AL., "Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease", BIOLOGICAL PSYCHIATRY, (2006), vol. 60, pages 1314 - 1323-
INTERNATIONAL-SEARCH-REPORT- MATTHIAS CACQUEVEL ET AL, "Modelling Alzheimer's disease through Adeno-Associated Virus (AAV) vector gene delivery in the mouse brain", ALZHEIMER'S & DEMENTIA, (201107), vol. 7, no. 4, doi:10.1016/j.jalz.2011.05.315, ISSN 1552-5260, pages S121 - S122, XP055093904 [X] 1,4,6,8-10 * abstract *
INTERNATIONAL-SEARCH-REPORT- BLANCHARD VRONIQUE ET AL, "Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice", EXPERIMENTAL NEUROLOGY, ACADEMIC PRESS, NEW YORK, NY, US, (200311), vol. 184, no. 1, doi:10.1016/S0014-4886(03)00252-8, ISSN 0014-4886, pages 247 - 263, XP002290685 [Y] 3 * table 3 *
INTERNATIONAL-SEARCH-REPORT- PEEL A L ET AL, "Adeno-associated virus vectors: activity and applications in the CNS", JOURNAL OF NEUROSCIENCE METHODS, ELSEVIER SCIENCE PUBLISHER B.V., AMSTERDAM, NL, vol. 98, no. 2, doi:10.1016/S0165-0270(00)00183-7, ISSN 0165-0270, (200006), pages 95 - 104, (20000601), XP026562614 [A] 7-11 * page 101 - page 102 *
INTERNATIONAL-SEARCH-REPORT- JOANNA L JANKOWSKY ET AL, "Co-expression of multiple transgenes in mouse CNS: a comparison of strategies", BIOMOLECULAR ENGINEERING, (200106), vol. 17, no. 6, doi:10.1016/S1389-0344(01)00067-3, ISSN 1389-0344, pages 157 - 165, XP055094007 [X] 1,2 * page 158; figure 1 * [Y] 3
INTERNATIONAL-SEARCH-REPORT- QINXI GUO ET AL, "APP physiological and pathophysiological functions: insights from animal models", CELL RESEARCH, (20110719), vol. 22, no. 1, doi:10.1038/cr.2011.116, ISSN 1001-0602, pages 78 - 89, XP055093873 [Y] 3 * table 1 *
INTERNATIONAL-SEARCH-REPORT- RONALD L KLEIN ET AL, "AAV8, 9, Rh10, Rh43 Vector Gene Transfer in the Rat Brain: Effects of Serotype, Promoter and Purification Method", MOLECULAR THERAPY, (20071023), vol. 16, no. 1, doi:10.1038/sj.mt.6300331, ISSN 1525-0016, pages 89 - 96, XP055094002 [A] 7 * page 94 - page 95 *
OPPOSITION- BAILEY J. et al., "Non-human Primates in Neuroscience Research: The Case Against its Scientific Necessity", ATLA, (20160000), vol. 44, pages 43 - 69, XP055962952-
OPPOSITION- Bailey J., Et Al., "Non-human Primates in Neuroscience Research: The Case Against its Scientific Necessity", ATLA, (20160101), vol. 44, pages 43 - 69, XP055962952-
OPPOSITION- BAILEY, J., "Lessons from Chimpanzee-based Research on Human Disease: The Implications of Genetic Differences", ATLA, (20110000), vol. 39, pages 527 - 540-
OPPOSITION- BAILEY, J., "Lessons from Chimpanzee-based Research on Human Disease: The Implications of Genetic Differences", ATLA, (20110000), vol. 39, pages 527 - 540, XP055962945-
OPPOSITION- BAILEY, J., "Lessons from Chimpanzee-based Research on Human Disease: The Implications of Genetic Differences", ATLA, (20110000), vol. 39, pages 527 - 540, XP091313768-
OPPOSITION- BAILEY, J., "Monkey-based Research on Human Disease: The Implications of Genetic Differences", ATLA, (20140000), vol. 42, pages 287 - 317, XP055962950-
OPPOSITION- Bailey J., "Monkey-based Research on Human Disease: The Implications of Genetic Differences", ATLA, (20140101), vol. 42, pages 287 - 317, XP055962950-
OPPOSITION- Beckman D et al, A novel tau-based mesus monkey model of Alzheimer's pathogenesis Alzheimers Dement 2021 Jun,17(6) 933-945-
OPPOSITION- REARDON S., "Alzheimer's researchers seek better mice / Several teams are developing animal models that more closely mimic the disease in people", Nature, (20180000), vol. 563, no. 611, pages 1 - 2, XP055962951-
OPPOSITION- Reardon S., "Alzheimer's researchers seek better mice / Several teams are developing animal models that more closely mimic the disease in people", Nature, (20180101), vol. 563, no. 611, pages 1 - 2, XP055962951-
OPPOSITION- Then C, "Stop investment in animal suffering', Patents on animals and new methods in genetic engineering: Economic interests leading to an increasing number of animal experiments", HYPERLINK, (20150101), HYPERLINK, (20160526), XP055275699-
OPPOSITION- THEN C, "Stop investment in animal suffering', Patents on animals and new methods in genetic engineering: Economic interests leading to an increasing number of animal experiments", Testbiotech, (20150000), pages 1 - 22, URL: www.testbiotech.org/node/1266, XP055275699-
OPPOSITION- CUMMINGS J.L. et al., "Alzheimer's disease drug-development pipeline: few candidates, frequent failures", Alzheimer's Research & Therapy, (20140000), vol. 6, doi:10.1186/alzrt269, page 37, XP021191407

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents